{"entity":{"type":"insider","cik":"0001635088","url":"/insider/0001635088","json_url":"/insider/0001635088.json","name":"Roivant Sciences Ltd.","name_source":"as-filed","also_issuer":true,"cross_url":"/issuer/0001635088"},"coverage_statement":{"n_transactions":52,"n_filings":27,"first":"2018-04-04","last":"2025-12-12","span_basis":"filed_date"},"name_variants":[{"name":"Roivant Sciences Ltd.","source":"filing","n_filings":27,"first_seen":"2018-04-04","last_seen":"2025-12-12"}],"transactions":[{"id":4092470,"accession":"0001140361-25-045409","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-045409","line_url":"/filing/0001140361-25-045409#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16666666.0,"shares_display":"16,666,666","price_per_share":21.0,"price_display":"21.00","price_state":"stated","total_value":349999986.0,"total_display":"349,999,986.00","total_whole":"349,999,986","shares_owned_after":113317007.0,"shares_owned_after_display":"113,317,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-12","filed_date":"2025-12-12","scope":"insider"},{"id":4092165,"accession":"0001140361-25-001188","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-001188","line_url":"/filing/0001140361-25-001188#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16845010.0,"shares_display":"16,845,010","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":336900200.0,"total_display":"336,900,200.00","total_whole":"336,900,200","shares_owned_after":96650341.0,"shares_owned_after_display":"96,650,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-13","filed_date":"2025-01-15","scope":"insider"},{"id":7894919,"accession":"0001140361-23-046976","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-23-046976","line_url":"/filing/0001140361-23-046976#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1526316.0,"shares_display":"1,526,316","price_per_share":38.0,"price_display":"38.00","price_state":"stated","total_value":58000008.0,"total_display":"58,000,008.00","total_whole":"58,000,008","shares_owned_after":79805331.0,"shares_owned_after_display":"79,805,331","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-02","filed_date":"2023-10-04","scope":"insider"},{"id":6141329,"accession":"0001140361-22-036652","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-036652","line_url":"/filing/0001140361-22-036652#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":416667.0,"shares_display":"416,667","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":2500002.0,"total_display":"2,500,002.00","total_whole":"2,500,002","shares_owned_after":73805331.0,"shares_owned_after_display":"73,805,331","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-06","filed_date":"2022-10-07","scope":"insider"},{"id":2078021,"accession":"0001104659-20-102701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-102701","line_url":"/filing/0001104659-20-102701#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":380000.0,"shares_display":"380,000","price_per_share":33.0,"price_display":"33.00","price_state":"stated","total_value":12540000.0,"total_display":"12,540,000.00","total_whole":"12,540,000","shares_owned_after":47593419.0,"shares_owned_after_display":"47,593,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-04","filed_date":"2020-09-04","scope":"insider"},{"id":2639314,"accession":"0001104659-20-048301","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-048301","line_url":"/filing/0001104659-20-048301#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1034483.0,"shares_display":"1,034,483","price_per_share":14.5,"price_display":"14.50","price_state":"stated","total_value":15000003.5,"total_display":"15,000,003.50","total_whole":"15,000,004","shares_owned_after":38439450.0,"shares_owned_after_display":"38,439,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-16","filed_date":"2020-04-17","scope":"insider"},{"id":2995354,"accession":"0001104659-20-026412","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-026412","line_url":"/filing/0001104659-20-026412#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Axovant Gene Therapies Ltd.","issuer_ticker":"AXGT","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.00001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5333333.0,"shares_display":"5,333,333","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":19999998.75,"total_display":"19,999,998.75","total_whole":"19,999,999","shares_owned_after":18577380.0,"shares_owned_after_display":"18,577,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-24","filed_date":"2020-02-27","scope":"insider"},{"id":8281765,"accession":"0001104659-19-077346","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-077346","line_url":"/filing/0001104659-19-077346#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22860013.0,"shares_display":"22,860,013","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-27","filed_date":"2019-12-31","scope":"insider"},{"id":7889464,"accession":"0001104659-19-077345","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-077345","line_url":"/filing/0001104659-19-077345#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000017727 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45008604.0,"shares_display":"45,008,604","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-27","filed_date":"2019-12-31","scope":"insider"},{"id":8510740,"accession":"0001104659-19-073807","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-073807","line_url":"/filing/0001104659-19-073807#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000017727 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":15.94,"price_display":"15.94","price_state":"stated","total_value":1195500.0,"total_display":"1,195,500.00","total_whole":"1,195,500","shares_owned_after":45008604.0,"shares_owned_after_display":"45,008,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-17","filed_date":"2019-12-18","scope":"insider"},{"id":8510737,"accession":"0001104659-19-073807","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-073807","line_url":"/filing/0001104659-19-073807","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000017727 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":170000.0,"shares_display":"170,000","price_per_share":15.130622882352942,"price_display":"15.13","price_state":"stated","total_value":2572205.89,"total_display":"2,572,205.89","total_whole":"2,572,206","shares_owned_after":44895145.0,"shares_owned_after_display":"44,895,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-16","filed_date":"2019-12-18","scope":"insider","n_lines":2},{"id":8380061,"accession":"0001104659-19-069974","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-19-069974","line_url":"/filing/0001104659-19-069974","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000017727 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":17.0575344,"price_display":"17.06","price_state":"stated","total_value":1279315.08,"total_display":"1,279,315.08","total_whole":"1,279,315","shares_owned_after":44761075.0,"shares_owned_after_display":"44,761,075","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-04","filed_date":"2019-12-04","scope":"insider","n_lines":2},{"id":8380053,"accession":"0001104659-19-069974","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-069974","line_url":"/filing/0001104659-19-069974","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000017727 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":179193.0,"shares_display":"179,193","price_per_share":18.444026998822498,"price_display":"18.44","price_state":"stated","total_value":3305040.53,"total_display":"3,305,040.53","total_whole":"3,305,041","shares_owned_after":44623079.0,"shares_owned_after_display":"44,623,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-02","filed_date":"2019-12-04","scope":"insider","n_lines":2},{"id":7889400,"accession":"0001104659-19-068249","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-068249","line_url":"/filing/0001104659-19-068249#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000017727 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500000.0,"shares_display":"3,500,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":52500000.0,"total_display":"52,500,000.00","total_whole":"52,500,000","shares_owned_after":44509411.0,"shares_owned_after_display":"44,509,411","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-25","filed_date":"2019-11-27","scope":"insider"},{"id":8237882,"accession":"0001104659-19-066768","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-066768","line_url":"/filing/0001104659-19-066768","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000017727 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":121906.0,"shares_display":"121,906","price_per_share":11.887033780125671,"price_display":"11.89","price_state":"stated","total_value":1449100.74,"total_display":"1,449,100.74","total_whole":"1,449,101","shares_owned_after":40991118.0,"shares_owned_after_display":"40,991,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-21","filed_date":"2019-11-22","scope":"insider","n_lines":2},{"id":8237875,"accession":"0001104659-19-066768","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-066768","line_url":"/filing/0001104659-19-066768#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000017727 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":121906.0,"shares_display":"121,906","price_per_share":12.9,"price_display":"12.90","price_state":"stated","total_value":1572587.4,"total_display":"1,572,587.40","total_whole":"1,572,587","shares_owned_after":40887505.0,"shares_owned_after_display":"40,887,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-20","filed_date":"2019-11-22","scope":"insider"},{"id":8379838,"accession":"0001104659-19-036412","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-036412","line_url":"/filing/0001104659-19-036412#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4957.0,"shares_display":"4,957","price_per_share":8.1693,"price_display":"8.17","price_state":"stated","total_value":40495.2201,"total_display":"40,495.22","total_whole":"40,495","shares_owned_after":22860013.0,"shares_owned_after_display":"22,860,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-19","filed_date":"2019-06-19","scope":"insider"},{"id":8379834,"accession":"0001104659-19-036412","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-036412","line_url":"/filing/0001104659-19-036412#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6706.0,"shares_display":"6,706","price_per_share":8.2107,"price_display":"8.21","price_state":"stated","total_value":55060.9542,"total_display":"55,060.95","total_whole":"55,061","shares_owned_after":22855056.0,"shares_owned_after_display":"22,855,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-18","filed_date":"2019-06-19","scope":"insider"},{"id":8379832,"accession":"0001104659-19-036412","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-036412","line_url":"/filing/0001104659-19-036412#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6541.0,"shares_display":"6,541","price_per_share":8.5346,"price_display":"8.53","price_state":"stated","total_value":55824.8186,"total_display":"55,824.82","total_whole":"55,825","shares_owned_after":22848350.0,"shares_owned_after_display":"22,848,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-17","filed_date":"2019-06-19","scope":"insider"},{"id":8613987,"accession":"0001104659-19-035730","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-035730","line_url":"/filing/0001104659-19-035730#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7144.0,"shares_display":"7,144","price_per_share":7.9107,"price_display":"7.91","price_state":"stated","total_value":56514.0408,"total_display":"56,514.04","total_whole":"56,514","shares_owned_after":22841809.0,"shares_owned_after_display":"22,841,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-14","filed_date":"2019-06-14","scope":"insider"},{"id":8613985,"accession":"0001104659-19-035730","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-035730","line_url":"/filing/0001104659-19-035730#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7367.0,"shares_display":"7,367","price_per_share":7.9466,"price_display":"7.95","price_state":"stated","total_value":58542.6022,"total_display":"58,542.60","total_whole":"58,543","shares_owned_after":22834665.0,"shares_owned_after_display":"22,834,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-13","filed_date":"2019-06-14","scope":"insider"},{"id":8613982,"accession":"0001104659-19-035730","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-035730","line_url":"/filing/0001104659-19-035730#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":8.2992,"price_display":"8.30","price_state":"stated","total_value":62244.0,"total_display":"62,244.00","total_whole":"62,244","shares_owned_after":22827298.0,"shares_owned_after_display":"22,827,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-12","filed_date":"2019-06-14","scope":"insider"},{"id":8582187,"accession":"0001104659-19-034827","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-034827","line_url":"/filing/0001104659-19-034827#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7189.0,"shares_display":"7,189","price_per_share":8.5817,"price_display":"8.58","price_state":"stated","total_value":61693.8413,"total_display":"61,693.84","total_whole":"61,694","shares_owned_after":22819798.0,"shares_owned_after_display":"22,819,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-11","filed_date":"2019-06-11","scope":"insider"},{"id":8582182,"accession":"0001104659-19-034827","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-034827","line_url":"/filing/0001104659-19-034827#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":8.3459,"price_display":"8.35","price_state":"stated","total_value":62594.25,"total_display":"62,594.25","total_whole":"62,594","shares_owned_after":22812609.0,"shares_owned_after_display":"22,812,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-10","filed_date":"2019-06-11","scope":"insider"},{"id":8582178,"accession":"0001104659-19-034827","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-034827","line_url":"/filing/0001104659-19-034827#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6649.0,"shares_display":"6,649","price_per_share":7.965,"price_display":"7.96","price_state":"stated","total_value":52959.285,"total_display":"52,959.28","total_whole":"52,959","shares_owned_after":22805109.0,"shares_owned_after_display":"22,805,109","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-07","filed_date":"2019-06-11","scope":"insider"},{"id":8582172,"accession":"0001104659-19-034351","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-034351","line_url":"/filing/0001104659-19-034351#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7082.0,"shares_display":"7,082","price_per_share":7.9951,"price_display":"8.00","price_state":"stated","total_value":56621.2982,"total_display":"56,621.30","total_whole":"56,621","shares_owned_after":22798460.0,"shares_owned_after_display":"22,798,460","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-06","filed_date":"2019-06-06","scope":"insider"},{"id":8582170,"accession":"0001104659-19-034351","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-034351","line_url":"/filing/0001104659-19-034351#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6540.0,"shares_display":"6,540","price_per_share":8.015,"price_display":"8.02","price_state":"stated","total_value":52418.1,"total_display":"52,418.10","total_whole":"52,418","shares_owned_after":22791378.0,"shares_owned_after_display":"22,791,378","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-05","filed_date":"2019-06-06","scope":"insider"},{"id":8582165,"accession":"0001104659-19-034351","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-034351","line_url":"/filing/0001104659-19-034351#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":7.5881,"price_display":"7.59","price_state":"stated","total_value":56910.75,"total_display":"56,910.75","total_whole":"56,911","shares_owned_after":22784838.0,"shares_owned_after_display":"22,784,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-04","filed_date":"2019-06-06","scope":"insider"},{"id":7943445,"accession":"0001104659-19-034348","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-034348","line_url":"/filing/0001104659-19-034348#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Myovant Sciences Ltd.","issuer_ticker":"MYOV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000017727 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2424242.0,"shares_display":"2,424,242","price_per_share":8.25,"price_display":"8.25","price_state":"stated","total_value":19999996.5,"total_display":"19,999,996.50","total_whole":"19,999,997","shares_owned_after":40765599.0,"shares_owned_after_display":"40,765,599","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-04","filed_date":"2019-06-06","scope":"insider"},{"id":8379798,"accession":"0001104659-19-033504","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-19-033504","line_url":"/filing/0001104659-19-033504#line-4","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5424.0,"shares_display":"5,424","price_per_share":7.7092,"price_display":"7.71","price_state":"stated","total_value":41814.7008,"total_display":"41,814.70","total_whole":"41,815","shares_owned_after":22777338.0,"shares_owned_after_display":"22,777,338","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-03","filed_date":"2019-06-03","scope":"insider"},{"id":8379793,"accession":"0001104659-19-033504","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-033504","line_url":"/filing/0001104659-19-033504#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5071.0,"shares_display":"5,071","price_per_share":7.6991,"price_display":"7.70","price_state":"stated","total_value":39042.1361,"total_display":"39,042.14","total_whole":"39,042","shares_owned_after":22771914.0,"shares_owned_after_display":"22,771,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-31","filed_date":"2019-06-03","scope":"insider"},{"id":8379791,"accession":"0001104659-19-033504","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-033504","line_url":"/filing/0001104659-19-033504","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7251.0,"shares_display":"7,251","price_per_share":8.011242945800578,"price_display":"8.01","price_state":"stated","total_value":58089.5226,"total_display":"58,089.52","total_whole":"58,090","shares_owned_after":22766543.0,"shares_owned_after_display":"22,766,543","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-30","filed_date":"2019-06-03","scope":"insider","n_lines":2},{"id":8145857,"accession":"0001104659-19-032471","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-032471","line_url":"/filing/0001104659-19-032471#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6882.0,"shares_display":"6,882","price_per_share":7.5535,"price_display":"7.55","price_state":"stated","total_value":51983.187,"total_display":"51,983.19","total_whole":"51,983","shares_owned_after":22759592.0,"shares_owned_after_display":"22,759,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-29","filed_date":"2019-05-29","scope":"insider"},{"id":8145851,"accession":"0001104659-19-032471","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-032471","line_url":"/filing/0001104659-19-032471#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3807.0,"shares_display":"3,807","price_per_share":7.6818,"price_display":"7.68","price_state":"stated","total_value":29244.6126,"total_display":"29,244.61","total_whole":"29,245","shares_owned_after":22752710.0,"shares_owned_after_display":"22,752,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-28","filed_date":"2019-05-29","scope":"insider"},{"id":8145846,"accession":"0001104659-19-032471","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-032471","line_url":"/filing/0001104659-19-032471#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3796.0,"shares_display":"3,796","price_per_share":7.7011,"price_display":"7.70","price_state":"stated","total_value":29233.3756,"total_display":"29,233.38","total_whole":"29,233","shares_owned_after":22748903.0,"shares_owned_after_display":"22,748,903","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-24","filed_date":"2019-05-29","scope":"insider"},{"id":8699006,"accession":"0001104659-19-031524","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-031524","line_url":"/filing/0001104659-19-031524#line-3","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4802.0,"shares_display":"4,802","price_per_share":7.7576,"price_display":"7.76","price_state":"stated","total_value":37251.9952,"total_display":"37,252.00","total_whole":"37,252","shares_owned_after":22745107.0,"shares_owned_after_display":"22,745,107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-23","filed_date":"2019-05-23","scope":"insider"},{"id":8699002,"accession":"0001104659-19-031524","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-031524","line_url":"/filing/0001104659-19-031524#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5033.0,"shares_display":"5,033","price_per_share":8.0584,"price_display":"8.06","price_state":"stated","total_value":40557.9272,"total_display":"40,557.93","total_whole":"40,558","shares_owned_after":22740305.0,"shares_owned_after_display":"22,740,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-22","filed_date":"2019-05-23","scope":"insider"},{"id":8698999,"accession":"0001104659-19-031524","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-031524","line_url":"/filing/0001104659-19-031524#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9995.0,"shares_display":"9,995","price_per_share":8.5151,"price_display":"8.52","price_state":"stated","total_value":85108.4245,"total_display":"85,108.42","total_whole":"85,108","shares_owned_after":22735272.0,"shares_owned_after_display":"22,735,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-21","filed_date":"2019-05-23","scope":"insider"},{"id":8310175,"accession":"0001104659-19-030609","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-19-030609","line_url":"/filing/0001104659-19-030609","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":8.0524831,"price_display":"8.05","price_state":"stated","total_value":80524.831,"total_display":"80,524.83","total_whole":"80,525","shares_owned_after":22723562.0,"shares_owned_after_display":"22,723,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-20","filed_date":"2019-05-20","scope":"insider","n_lines":2},{"id":8310170,"accession":"0001104659-19-030609","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-030609","line_url":"/filing/0001104659-19-030609#line-2","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6200.0,"shares_display":"6,200","price_per_share":7.3615,"price_display":"7.36","price_state":"stated","total_value":45641.3,"total_display":"45,641.30","total_whole":"45,641","shares_owned_after":22715277.0,"shares_owned_after_display":"22,715,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-17","filed_date":"2019-05-20","scope":"insider"},{"id":8310168,"accession":"0001104659-19-030609","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-030609","line_url":"/filing/0001104659-19-030609#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5408.0,"shares_display":"5,408","price_per_share":6.7896,"price_display":"6.79","price_state":"stated","total_value":36718.1568,"total_display":"36,718.16","total_whole":"36,718","shares_owned_after":22709077.0,"shares_owned_after_display":"22,709,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-16","filed_date":"2019-05-20","scope":"insider"},{"id":8237357,"accession":"0001104659-19-016010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-016010","line_url":"/filing/0001104659-19-016010#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Axovant Sciences Ltd.","issuer_ticker":"AXON","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.00001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6666667.0,"shares_display":"6,666,667","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":10000000.5,"total_display":"10,000,000.50","total_whole":"10,000,001","shares_owned_after":105952381.0,"shares_owned_after_display":"105,952,381","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-18","filed_date":"2019-03-19","scope":"insider"},{"id":6044077,"accession":"0001104659-18-073897","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-073897","line_url":"/filing/0001104659-18-073897#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Axovant Sciences Ltd.","issuer_ticker":"AXON","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.00001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000000.0,"shares_display":"10,000,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":99285714.0,"shares_owned_after_display":"99,285,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-18","filed_date":"2018-12-20","scope":"insider"},{"id":6288983,"accession":"0001104659-18-060344","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-060344","line_url":"/filing/0001104659-18-060344#line-1","is_derivative":false,"issuer_cik":"0001635088","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001635088","owner_cik":"0001635088","owner_name":"Roivant Sciences Ltd.","owner_display_name":"Roivant Sciences Ltd.","owner_url":"/insider/0001635088","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, par value $0.000037453 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2678571.0,"shares_display":"2,678,571","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":37499994.0,"total_display":"37,499,994.00","total_whole":"37,499,994","shares_owned_after":22703669.0,"shares_owned_after_display":"22,703,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-01","filed_date":"2018-10-03","scope":"insider"}],"collapsed":true,"next_cursor":"2018-10-01|6288983","ledger_fault":false,"count":{"value":52,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":50,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":52},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001764013","name":"Immunovant, Inc.","url":"/issuer/0001764013","role":"Director, Ten percent owner","n_filings":6,"first_seen":"2020-04-17","last_seen":"2025-12-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001636050","name":"Axovant Gene Therapies Ltd.","url":"/issuer/0001636050","role":"Ten percent owner","n_filings":4,"first_seen":"2018-06-07","last_seen":"2020-02-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001679082","name":"Myovant Sciences Ltd.","url":"/issuer/0001679082","role":"Ten percent owner","n_filings":7,"first_seen":"2018-04-04","last_seen":"2019-12-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001740547","name":"Urovant Sciences Ltd.","url":"/issuer/0001740547","role":"Ten percent owner","n_filings":10,"first_seen":"2018-10-03","last_seen":"2019-12-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001635088","retrieved_at":"2026-08-25T23:19:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}